New histone deacetylase inhibitors improve cisplatin antitumor properties against thoracic cancer cells

Histone deacetylase inhibitors (HDACi) have shown promising antitumor effects on numerous cancer cells including malignant pleural mesothelioma (MPM) and lung adenocarcinoma (ADCA) cells. However, clinical trials using these compounds alone have shown limited efficacy against solid tumors. Therefore...

Descripción completa

Detalles Bibliográficos
Autores principales: Gueugnon, Fabien, Cartron, Pierre-François, Charrier, Cedric, Bertrand, Philippe, Fonteneau, Jean-François, Gregoire, Marc, Blanquart, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147341/
https://www.ncbi.nlm.nih.gov/pubmed/24980825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147341/
https://www.ncbi.nlm.nih.gov/pubmed/24980825

Ejemplares similares